mTOR and rapamycin research pioneer, former Buck Institute CEO
Brian Kennedy is a leading researcher on the biology of aging who previously served as CEO of the Buck Institute. His work focuses on mTOR signaling and how interventions like rapamycin can extend lifespan. Now at the National University of Singapore, he's working to translate laboratory findings into human therapies and has been instrumental in advancing our understanding of how nutrient-sensing pathways regulate aging.